Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication

We retrospectively evaluated whether antiplatelet preparation lowered the thromboembolic complication rate during the perioperative period. We reviewed 328 elective coil embolization procedures in which only microcatheters were used for coiling. No antiplatelet medication was prescribed before the p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurosurgery 2010-09, Vol.67 (3), p.743-748
Hauptverfasser: Hwang, Gyojun, Jung, Chulkyu, Park, Sukh Que, Kang, Hyun Sung, Lee, Sang Hyung, Oh, Chang Wan, Chung, Young Seob, Han, Moon Hee, Kwon, O-Ki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 748
container_issue 3
container_start_page 743
container_title Neurosurgery
container_volume 67
creator Hwang, Gyojun
Jung, Chulkyu
Park, Sukh Que
Kang, Hyun Sung
Lee, Sang Hyung
Oh, Chang Wan
Chung, Young Seob
Han, Moon Hee
Kwon, O-Ki
description We retrospectively evaluated whether antiplatelet preparation lowered the thromboembolic complication rate during the perioperative period. We reviewed 328 elective coil embolization procedures in which only microcatheters were used for coiling. No antiplatelet medication was prescribed before the procedure in 95 cases (29%, group 1), whereas antiplatelet therapy was used in 233 cases (71%, group 2; 61 [18.6%] with a single agent [aspirin or clopidogrel] and 172 [52.4%] with both agents). Antiplatelet agents were not given after coiling unless atherosclerosis, severe coil protrusion, or a thromboembolic complication occurred during the procedure. A thromboembolic complication was defined as a procedural thromboembolic event or transient ischemic attack or stroke occurring within 2 days of embolization. Thromboembolic complications occurred in 11 cases (3.4%): 6 (6.3%) in group 1 and 5 (2.1%) in group 2 (P = .085). In 195 cases (59.5%) treated by the single microcatheter technique, the risk of thromboembolic complications was low and not affected by antiplatelet preparation (1.8% [no preparation] vs 2.2% [preparation]; P = 1.000). However, in 133 cases (40.5%) treated by the multiple microcatheter technique, antiplatelet preparation significantly reduced the thromboembolic complication risk by 85.2% (12.8% [no preparation] vs 2.1% [preparation]; odds ratio, 0.148; 95% confidence interval, 0.027-0.798; P = .023). The aneurysms treated by the multiple microcatheter technique had more complex configurations for coiling (P < .001). The risk of hemorrhage was not increased by antiplatelet preparation (P = .171). Antiplatelet preparation lowered the periprocedural thromboembolic complication rate in unruptured aneurysms treated by the multiple microcatheter technique and did not increase the risk of hemorrhage. Therefore, antiplatelet preparation can help to reduce complications in patients in whom technical difficulties are expected without the risk of hemorrhage.
doi_str_mv 10.1227/01.NEU.0000374770.09140.FB
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_749005934</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2307721926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c289t-de8a38366c645f9feb6c64dff9dfa4e3e8232a60c7a686454c0f4f9193b9510c3</originalsourceid><addsrcrecordid>eNp1kd9qFTEQxoMo9lh9BVn0wqtdJ3822fTOlh4Vit604F3IyU7olt2TNckW6jv5jmZ7jgqCgTCB7zffTPgIeUOhoYyp90CbL5c3DZTDlVAKGtBUQLM9f0I2tGWiFiDgKdkAFV3Ntfx2Ql6kdAdApVDdc3LCQLZUMrUhP69vY5h2AcsdB1e5MM2l2jyEfaqCr3BEl4d7LMowVgfsx6O8qss-LnNeIvaV3eMSH9KUzqp8ixV6XxpXJkQ7FjUP82hzscvVHHG28Wiyr2aMwxyDw35Z0fz_jV6SZ96OCV8d6ym52V5eX3yqr75-_Hzx4ap2rNO57rGzvONSOilarz3u1lfvve69FcixY5xZCU5Z2RVEOPDCa6r5TrcUHD8l7w6-Za3vC6ZspiE5HMfyybAko4QGaDUXhXz7D3kXlrgvyxnGQSlGNZOFOjtQLoaUInozx2Gy8cFQMGumBqgpmZq_mZrHTM32vDS_Po5YdhP2f1p_h8h_Ae-6o6s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2307721926</pqid></control><display><type>article</type><title>Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Hwang, Gyojun ; Jung, Chulkyu ; Park, Sukh Que ; Kang, Hyun Sung ; Lee, Sang Hyung ; Oh, Chang Wan ; Chung, Young Seob ; Han, Moon Hee ; Kwon, O-Ki</creator><creatorcontrib>Hwang, Gyojun ; Jung, Chulkyu ; Park, Sukh Que ; Kang, Hyun Sung ; Lee, Sang Hyung ; Oh, Chang Wan ; Chung, Young Seob ; Han, Moon Hee ; Kwon, O-Ki</creatorcontrib><description>We retrospectively evaluated whether antiplatelet preparation lowered the thromboembolic complication rate during the perioperative period. We reviewed 328 elective coil embolization procedures in which only microcatheters were used for coiling. No antiplatelet medication was prescribed before the procedure in 95 cases (29%, group 1), whereas antiplatelet therapy was used in 233 cases (71%, group 2; 61 [18.6%] with a single agent [aspirin or clopidogrel] and 172 [52.4%] with both agents). Antiplatelet agents were not given after coiling unless atherosclerosis, severe coil protrusion, or a thromboembolic complication occurred during the procedure. A thromboembolic complication was defined as a procedural thromboembolic event or transient ischemic attack or stroke occurring within 2 days of embolization. Thromboembolic complications occurred in 11 cases (3.4%): 6 (6.3%) in group 1 and 5 (2.1%) in group 2 (P = .085). In 195 cases (59.5%) treated by the single microcatheter technique, the risk of thromboembolic complications was low and not affected by antiplatelet preparation (1.8% [no preparation] vs 2.2% [preparation]; P = 1.000). However, in 133 cases (40.5%) treated by the multiple microcatheter technique, antiplatelet preparation significantly reduced the thromboembolic complication risk by 85.2% (12.8% [no preparation] vs 2.1% [preparation]; odds ratio, 0.148; 95% confidence interval, 0.027-0.798; P = .023). The aneurysms treated by the multiple microcatheter technique had more complex configurations for coiling (P &lt; .001). The risk of hemorrhage was not increased by antiplatelet preparation (P = .171). Antiplatelet preparation lowered the periprocedural thromboembolic complication rate in unruptured aneurysms treated by the multiple microcatheter technique and did not increase the risk of hemorrhage. Therefore, antiplatelet preparation can help to reduce complications in patients in whom technical difficulties are expected without the risk of hemorrhage.</description><identifier>ISSN: 0148-396X</identifier><identifier>EISSN: 1524-4040</identifier><identifier>DOI: 10.1227/01.NEU.0000374770.09140.FB</identifier><identifier>PMID: 20651627</identifier><language>eng</language><publisher>United States: Wolters Kluwer Health, Inc</publisher><subject>Administration, Oral ; Aged ; Aneurysms ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Embolization, Therapeutic - adverse effects ; Embolization, Therapeutic - instrumentation ; Embolization, Therapeutic - methods ; Female ; Hemorrhage ; Humans ; Intracranial Aneurysm - physiopathology ; Intracranial Aneurysm - therapy ; Male ; Middle Aged ; Platelet Aggregation Inhibitors - administration &amp; dosage ; Postoperative Complications - drug therapy ; Postoperative Complications - physiopathology ; Postoperative Complications - prevention &amp; control ; Retrospective Studies ; Thromboembolism ; Thromboembolism - drug therapy ; Thromboembolism - physiopathology ; Thromboembolism - prevention &amp; control</subject><ispartof>Neurosurgery, 2010-09, Vol.67 (3), p.743-748</ispartof><rights>Copyright © 2010 by the Congress of Neurological Surgeons</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c289t-de8a38366c645f9feb6c64dff9dfa4e3e8232a60c7a686454c0f4f9193b9510c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20651627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hwang, Gyojun</creatorcontrib><creatorcontrib>Jung, Chulkyu</creatorcontrib><creatorcontrib>Park, Sukh Que</creatorcontrib><creatorcontrib>Kang, Hyun Sung</creatorcontrib><creatorcontrib>Lee, Sang Hyung</creatorcontrib><creatorcontrib>Oh, Chang Wan</creatorcontrib><creatorcontrib>Chung, Young Seob</creatorcontrib><creatorcontrib>Han, Moon Hee</creatorcontrib><creatorcontrib>Kwon, O-Ki</creatorcontrib><title>Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication</title><title>Neurosurgery</title><addtitle>Neurosurgery</addtitle><description>We retrospectively evaluated whether antiplatelet preparation lowered the thromboembolic complication rate during the perioperative period. We reviewed 328 elective coil embolization procedures in which only microcatheters were used for coiling. No antiplatelet medication was prescribed before the procedure in 95 cases (29%, group 1), whereas antiplatelet therapy was used in 233 cases (71%, group 2; 61 [18.6%] with a single agent [aspirin or clopidogrel] and 172 [52.4%] with both agents). Antiplatelet agents were not given after coiling unless atherosclerosis, severe coil protrusion, or a thromboembolic complication occurred during the procedure. A thromboembolic complication was defined as a procedural thromboembolic event or transient ischemic attack or stroke occurring within 2 days of embolization. Thromboembolic complications occurred in 11 cases (3.4%): 6 (6.3%) in group 1 and 5 (2.1%) in group 2 (P = .085). In 195 cases (59.5%) treated by the single microcatheter technique, the risk of thromboembolic complications was low and not affected by antiplatelet preparation (1.8% [no preparation] vs 2.2% [preparation]; P = 1.000). However, in 133 cases (40.5%) treated by the multiple microcatheter technique, antiplatelet preparation significantly reduced the thromboembolic complication risk by 85.2% (12.8% [no preparation] vs 2.1% [preparation]; odds ratio, 0.148; 95% confidence interval, 0.027-0.798; P = .023). The aneurysms treated by the multiple microcatheter technique had more complex configurations for coiling (P &lt; .001). The risk of hemorrhage was not increased by antiplatelet preparation (P = .171). Antiplatelet preparation lowered the periprocedural thromboembolic complication rate in unruptured aneurysms treated by the multiple microcatheter technique and did not increase the risk of hemorrhage. Therefore, antiplatelet preparation can help to reduce complications in patients in whom technical difficulties are expected without the risk of hemorrhage.</description><subject>Administration, Oral</subject><subject>Aged</subject><subject>Aneurysms</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Schedule</subject><subject>Embolization, Therapeutic - adverse effects</subject><subject>Embolization, Therapeutic - instrumentation</subject><subject>Embolization, Therapeutic - methods</subject><subject>Female</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Intracranial Aneurysm - physiopathology</subject><subject>Intracranial Aneurysm - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Platelet Aggregation Inhibitors - administration &amp; dosage</subject><subject>Postoperative Complications - drug therapy</subject><subject>Postoperative Complications - physiopathology</subject><subject>Postoperative Complications - prevention &amp; control</subject><subject>Retrospective Studies</subject><subject>Thromboembolism</subject><subject>Thromboembolism - drug therapy</subject><subject>Thromboembolism - physiopathology</subject><subject>Thromboembolism - prevention &amp; control</subject><issn>0148-396X</issn><issn>1524-4040</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kd9qFTEQxoMo9lh9BVn0wqtdJ3822fTOlh4Vit604F3IyU7olt2TNckW6jv5jmZ7jgqCgTCB7zffTPgIeUOhoYyp90CbL5c3DZTDlVAKGtBUQLM9f0I2tGWiFiDgKdkAFV3Ntfx2Ql6kdAdApVDdc3LCQLZUMrUhP69vY5h2AcsdB1e5MM2l2jyEfaqCr3BEl4d7LMowVgfsx6O8qss-LnNeIvaV3eMSH9KUzqp8ixV6XxpXJkQ7FjUP82hzscvVHHG28Wiyr2aMwxyDw35Z0fz_jV6SZ96OCV8d6ym52V5eX3yqr75-_Hzx4ap2rNO57rGzvONSOilarz3u1lfvve69FcixY5xZCU5Z2RVEOPDCa6r5TrcUHD8l7w6-Za3vC6ZspiE5HMfyybAko4QGaDUXhXz7D3kXlrgvyxnGQSlGNZOFOjtQLoaUInozx2Gy8cFQMGumBqgpmZq_mZrHTM32vDS_Po5YdhP2f1p_h8h_Ae-6o6s</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>Hwang, Gyojun</creator><creator>Jung, Chulkyu</creator><creator>Park, Sukh Que</creator><creator>Kang, Hyun Sung</creator><creator>Lee, Sang Hyung</creator><creator>Oh, Chang Wan</creator><creator>Chung, Young Seob</creator><creator>Han, Moon Hee</creator><creator>Kwon, O-Ki</creator><general>Wolters Kluwer Health, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201009</creationdate><title>Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication</title><author>Hwang, Gyojun ; Jung, Chulkyu ; Park, Sukh Que ; Kang, Hyun Sung ; Lee, Sang Hyung ; Oh, Chang Wan ; Chung, Young Seob ; Han, Moon Hee ; Kwon, O-Ki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c289t-de8a38366c645f9feb6c64dff9dfa4e3e8232a60c7a686454c0f4f9193b9510c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Administration, Oral</topic><topic>Aged</topic><topic>Aneurysms</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Schedule</topic><topic>Embolization, Therapeutic - adverse effects</topic><topic>Embolization, Therapeutic - instrumentation</topic><topic>Embolization, Therapeutic - methods</topic><topic>Female</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Intracranial Aneurysm - physiopathology</topic><topic>Intracranial Aneurysm - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Platelet Aggregation Inhibitors - administration &amp; dosage</topic><topic>Postoperative Complications - drug therapy</topic><topic>Postoperative Complications - physiopathology</topic><topic>Postoperative Complications - prevention &amp; control</topic><topic>Retrospective Studies</topic><topic>Thromboembolism</topic><topic>Thromboembolism - drug therapy</topic><topic>Thromboembolism - physiopathology</topic><topic>Thromboembolism - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hwang, Gyojun</creatorcontrib><creatorcontrib>Jung, Chulkyu</creatorcontrib><creatorcontrib>Park, Sukh Que</creatorcontrib><creatorcontrib>Kang, Hyun Sung</creatorcontrib><creatorcontrib>Lee, Sang Hyung</creatorcontrib><creatorcontrib>Oh, Chang Wan</creatorcontrib><creatorcontrib>Chung, Young Seob</creatorcontrib><creatorcontrib>Han, Moon Hee</creatorcontrib><creatorcontrib>Kwon, O-Ki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hwang, Gyojun</au><au>Jung, Chulkyu</au><au>Park, Sukh Que</au><au>Kang, Hyun Sung</au><au>Lee, Sang Hyung</au><au>Oh, Chang Wan</au><au>Chung, Young Seob</au><au>Han, Moon Hee</au><au>Kwon, O-Ki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication</atitle><jtitle>Neurosurgery</jtitle><addtitle>Neurosurgery</addtitle><date>2010-09</date><risdate>2010</risdate><volume>67</volume><issue>3</issue><spage>743</spage><epage>748</epage><pages>743-748</pages><issn>0148-396X</issn><eissn>1524-4040</eissn><abstract>We retrospectively evaluated whether antiplatelet preparation lowered the thromboembolic complication rate during the perioperative period. We reviewed 328 elective coil embolization procedures in which only microcatheters were used for coiling. No antiplatelet medication was prescribed before the procedure in 95 cases (29%, group 1), whereas antiplatelet therapy was used in 233 cases (71%, group 2; 61 [18.6%] with a single agent [aspirin or clopidogrel] and 172 [52.4%] with both agents). Antiplatelet agents were not given after coiling unless atherosclerosis, severe coil protrusion, or a thromboembolic complication occurred during the procedure. A thromboembolic complication was defined as a procedural thromboembolic event or transient ischemic attack or stroke occurring within 2 days of embolization. Thromboembolic complications occurred in 11 cases (3.4%): 6 (6.3%) in group 1 and 5 (2.1%) in group 2 (P = .085). In 195 cases (59.5%) treated by the single microcatheter technique, the risk of thromboembolic complications was low and not affected by antiplatelet preparation (1.8% [no preparation] vs 2.2% [preparation]; P = 1.000). However, in 133 cases (40.5%) treated by the multiple microcatheter technique, antiplatelet preparation significantly reduced the thromboembolic complication risk by 85.2% (12.8% [no preparation] vs 2.1% [preparation]; odds ratio, 0.148; 95% confidence interval, 0.027-0.798; P = .023). The aneurysms treated by the multiple microcatheter technique had more complex configurations for coiling (P &lt; .001). The risk of hemorrhage was not increased by antiplatelet preparation (P = .171). Antiplatelet preparation lowered the periprocedural thromboembolic complication rate in unruptured aneurysms treated by the multiple microcatheter technique and did not increase the risk of hemorrhage. Therefore, antiplatelet preparation can help to reduce complications in patients in whom technical difficulties are expected without the risk of hemorrhage.</abstract><cop>United States</cop><pub>Wolters Kluwer Health, Inc</pub><pmid>20651627</pmid><doi>10.1227/01.NEU.0000374770.09140.FB</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0148-396X
ispartof Neurosurgery, 2010-09, Vol.67 (3), p.743-748
issn 0148-396X
1524-4040
language eng
recordid cdi_proquest_miscellaneous_749005934
source MEDLINE; Journals@Ovid Complete
subjects Administration, Oral
Aged
Aneurysms
Dose-Response Relationship, Drug
Drug Administration Schedule
Embolization, Therapeutic - adverse effects
Embolization, Therapeutic - instrumentation
Embolization, Therapeutic - methods
Female
Hemorrhage
Humans
Intracranial Aneurysm - physiopathology
Intracranial Aneurysm - therapy
Male
Middle Aged
Platelet Aggregation Inhibitors - administration & dosage
Postoperative Complications - drug therapy
Postoperative Complications - physiopathology
Postoperative Complications - prevention & control
Retrospective Studies
Thromboembolism
Thromboembolism - drug therapy
Thromboembolism - physiopathology
Thromboembolism - prevention & control
title Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T04%3A02%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thromboembolic%20complications%20of%20elective%20coil%20embolization%20of%20unruptured%20aneurysms:%20the%20effect%20of%20oral%20antiplatelet%20preparation%20on%20periprocedural%20thromboembolic%20complication&rft.jtitle=Neurosurgery&rft.au=Hwang,%20Gyojun&rft.date=2010-09&rft.volume=67&rft.issue=3&rft.spage=743&rft.epage=748&rft.pages=743-748&rft.issn=0148-396X&rft.eissn=1524-4040&rft_id=info:doi/10.1227/01.NEU.0000374770.09140.FB&rft_dat=%3Cproquest_cross%3E2307721926%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2307721926&rft_id=info:pmid/20651627&rfr_iscdi=true